Equity · Basic Materials
BCPC
NASDAQBalchem (BCPC)
The line runs 178 USD on 24 August through 163.51 USD on 20 November, on a scale from 160 to 190. Days the market did not trade hold the previous close, flat.
- Market cap
- 5.2B USD
- P/E (TTM)
- 30.8
- Revenue, year to Dec 2025
- 1.0B USD
- EPS, diluted, year to Dec 2025
- 4.75 USD
- 52-week range
- 147.42 USD – 183.32 USD
- Avg volume
- 10.3K
as of Nov 20, 2026
Have Balchem (BCPC) insiders bought or sold shares recently?
BCPC's newest Form 4 filing is dated 12 February 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Dec 2025 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Sell | 6,000 | 920K USD |
| 03 Dec 2025 | Fischer David B | Sell | 8,000 | 1.2M USD |
| 11 Nov 2025 | Reid Martin LutherSVP Chief Supply Chain Officer | Sell | 1,200 | 185K USD |
| Sold | 3 open-market sales | 15,200 | $2.34M |
43 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 12 Feb 2026 | Bengtsson Carl MartinEVP & Chief Financial Officer | Tax withheld | 302 | 54K USD |
| 12 Feb 2026 | Miyata HatsukiEVP, CLO, & Secretary | Tax withheld | 181 | 32K USD |
| 12 Feb 2026 | Tignor Michael BrentSVP & Chief HR Officer | Tax withheld | 165 | 29K USD |
| 12 Feb 2026 | Boned FredericSVP/GM, Human Nutri. & Health | Tax withheld | 203 | 36K USD |
| 12 Feb 2026 | Backus William A.VP & Chief Accounting Officer | Tax withheld | 70 | 12K USD |
| 12 Feb 2026 | Harris Theodore LChairman, President & CEO | Tax withheld | 844 | 150K USD |
| 12 Feb 2026 | Reid Martin LutherSVP Chief Supply Chain Officer | Tax withheld | 116 | 21K USD |
| 12 Feb 2026 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Tax withheld | 58 | 10K USD |
| 11 Feb 2026 | Fischer David BDirector | Award | 870 | |
| 11 Feb 2026 | Fish Kathleen BDirector | Award | 870 | |
| 11 Feb 2026 | Knutson Daniel EDirector | Award | 870 | |
| 11 Feb 2026 | Rigaud OlivierDirector | Award | 870 |
Showing the 12 most recent of 43 compensation filings in this window. The figures above count all of them.
Which funds hold Balchem (BCPC)?
11 of the 45 institutional funds we track reported a Balchem position for the quarter ended 30 Sep 2026 — a combined 191.1M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Two Sigma Investments | Held (±25%) | 508,589 | 83.9M USD | +1.3% |
| Renaissance Technologies | Held (±25%) | 167,900 | 27.7M USD | −13.1% |
| AQR Capital Management | Held (±25%) | 86,428 | 14.3M USD | +16.1% |
| Marshall Wace | Held (±25%) | 86,228 | 14.2M USD | −11.9% |
| Citadel Advisors | Held (±25%) | 76,974 | 12.7M USD | +24.9% |
| Millennium Management | Trimmed | 74,547 | 12.3M USD | −59.6% |
| Point72 Asset Management | Added | 72,774 | 12.0M USD | +182.0% |
| Balyasny Asset Management | Held (±25%) | 49,542 | 8.2M USD | +3.4% |
| Bridgewater Associates | Held (±25%) | 14,571 | 2.4M USD | +8.6% |
| Tudor Investment Corp | New position | 13,058 | 2.2M USD |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded Balchem (BCPC)?
The most recent congressional trade disclosed in Balchem is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 17 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 17 Sep 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 25 days |
| 10 Jul 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 56 days |
| 09 Apr 2025 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 35 days |
What has been filed or recorded for Balchem (BCPC)?
The filings we hold for Balchem, newest first: 1 fails-to-deliver day, 4 quarterly earnings reports, 3 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Oct 2026 | Fails to deliver | Shares failed to deliver | 34 shares | 6K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 1.46 USD | |
| 30 Sep 2026 | Financials | Total assets | 1.7B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.3B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 1.39 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 1.25 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.21 USD | |
| 31 Dec 2025 | Financials | Revenue | 1.0B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 154.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 4.75 USD | fiscal year |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS 1.24 USD | |
| 30 Jun 2025 | Annual report | FY 2025 reported | EPS 1.17 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 1.13 USD |
What do people ask about Balchem (BCPC)?
What did Balchem shares close at?163.51
Balchem closed at 163.51 USD on 20 Nov 2026, down 1.33% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Balchem’s market cap?5.2B
Balchem is worth 5.2B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Balchem’s P/E ratio?30.8
Balchem has a price-to-earnings ratio of 30.8, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Balchem’s revenue?1.0B
Balchem reported revenue of 1.0B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Balchem insiders bought or sold shares recently?
No Balchem insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 12 Feb 2026 (SEC Form 4). See Insiders
Which funds own Balchem?11 of 45
11 of the 45 funds we track reported a Balchem position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Renaissance Technologies and AQR Capital Management. See Funds
Have members of Congress traded Balchem?3 trades
Yes. 3 trades in Balchem appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 17 Sep 2026, filed 12 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Balchem last report earnings?1.46
Balchem last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 1.46 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Gilbert Ray Cisneros, Jr.: United States Department of Defense, Public domain; Josh Gottheimer: Kristie Boyd; U.S. House Office of Photography, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words